Bayer antibleeding drug takes hit

By RACHEL ZIMMERMAN The antibleeding drug Trasylol, already pulled from the market amid safety concerns, may have received its final blow with a new study that shows it is associated with a greater risk of death compared to competing medications.Study Prompts Bayer to Pull Trasylol from the Market eFluxMediaBayer pulls Trasylol supplies after study ReutersWashington Post - The Associated Press - International Business Times - Forbes